FDA approves new, cheaper rival to EpiPen allergy shot

Thursday, June 15, 2017 - 17:21 in Health & Medicine

TRENTON, N.J. (AP) -- U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net